10X10 PACKING . GLIMEPIRIDE 2MG , VOGLIBOSE 0.2 MG AND METFORMIN HCL 500MG . CONTROLS SUGAR SPIKES . LIMITS CARBOHYDRATES ABSORPTION . SUPPORTS DIABETES.

Glimepiride, voglibose, and metformin hydrochloride tablets are a combination medication for treating Type 2 Diabetes Mellitus when diet, exercise, and other treatments are insufficient. This combination works in three ways: glimepiride stimulates insulin release, metformin reduces liver glucose production and improves insulin sensitivity, and voglibose slows sugar absorption after meals. This medication helps control blood glucose levels and reduce the risk of diabetes-related complications

Glimepiride increases the amount of insulin released by the pancreas, which lowers blood glucose levels.

Metformin decreases the amount of glucose produced by the liver and makes the body more sensitive to insulin, helping to lower blood glucose levels.

Voglibose is an alpha-glucosidase inhibitor that prevents the breakdown of complex carbohydrates into simple sugars (glucose) in the intestine, thereby reducing the rise in blood glucose levels after eating.